These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5151501)

  • 1. [Use of schemes of systematized description of changes in tonus and hyperkinesis for clinico-physiologic evaluation of the action of enurotropic pharmacologic preparations].
    Kambarova DK; Anichkov AD; Moiseeva NI; Movsisiants SA
    Sov Zdravookhr Kirg; 1971; 3():34-40. PubMed ID: 5151501
    [No Abstract]   [Full Text] [Related]  

  • 2. [Syndrome involving the extrapyramidal motor systems and their drug treatment].
    Soyka D
    Fortschr Med; 1974 Aug; 92(22):906-9. PubMed ID: 4153689
    [No Abstract]   [Full Text] [Related]  

  • 3. [Statokinesimetric study of the effect of minaprine on tonic postural activity in akineto-hypertonic Parkinson patients].
    Valade D; Baron JB
    Agressologie; 1983 Jan; 24(1):47-55. PubMed ID: 6869694
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pathochemical bases for the treatment of parkinsonism].
    Petelin LS; Tret'iakova KA; Pigarev VA; Romenskaia LK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1971 Dec; 71(12):1765-70. PubMed ID: 5143959
    [No Abstract]   [Full Text] [Related]  

  • 5. The drug treatment of Parkinson's disease.
    Drug Ther Bull; 1984 May; 22(10):37-40. PubMed ID: 6745095
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bulgarian antiparkinson preparations with a new mechanism of action].
    Ganev G; Karamalakov L; Tsekova M
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(12):1864-9. PubMed ID: 6000490
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacology of Parkinson's disease.
    Burton K; Calne DB
    Neurol Clin; 1984 Aug; 2(3):461-72. PubMed ID: 6152482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of the effects of muscle relaxant drugs in man by tonic stretch reflex.
    Meyer M; Adorjáni C
    Adv Neurol; 1983; 39():997-1011. PubMed ID: 6660131
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacologic treatment in Parkinson disease].
    García de Yébenes J; Fontán A; Rojo A
    Neurologia; 1999 May; 14 Suppl 1():17-33. PubMed ID: 10377727
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drugs and indications for medical treatment in Parkinson's disease (author's transl)].
    Allain H; Van den Driessche J; Menault F; Pape D; Reymann JM; Bentue-Ferrer D
    Sem Hop; 1980 Feb 8-15; 56(5-6):277-82. PubMed ID: 6243802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacologic treatment of gait ignition failure.
    Rascol O; Fabre N; Brefel-Courbon C; Montastruc JL
    Adv Neurol; 2001; 87():255-64. PubMed ID: 11347230
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antiparkinsonian drugs (author's transl)].
    Ando K
    No To Shinkei; 1980 Aug; 32(8):743-53. PubMed ID: 7008813
    [No Abstract]   [Full Text] [Related]  

  • 13. Shuffling slowly forwards: recent advances in Parkinson's disease management.
    Donaldson I; Anderson T
    N Z Med J; 1998 Jun; 111(1067):197-8. PubMed ID: 9673631
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of Parkinson's disease with controlled-release Carbidopa/L-DOPA.
    Pahwa R; Koller WC
    Adv Neurol; 1996; 69():487-91. PubMed ID: 8615169
    [No Abstract]   [Full Text] [Related]  

  • 15. [New pharmacologic strategies for the treatment of Parkinson disease].
    Tolosa E; Molinuevo JL; Valldeoriola F; Pastor P
    Neurologia; 1999 May; 14 Suppl 1():46-53. PubMed ID: 10377729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic effectiveness of modern antiparkinson agents].
    Kurako IuL; Volianskiĭ VE; Fadeev SM
    Vrach Delo; 1981 Feb; (2):7-11. PubMed ID: 7222616
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative study of 2 new antiparkinson drugs (UCB 1549 and SD 25)].
    Strang RR
    Nord Med; 1966 Oct; 76(43):1245-7. PubMed ID: 5918116
    [No Abstract]   [Full Text] [Related]  

  • 18. Mefexamide as an antiparkinson drug. (A double-blind study).
    Denber HC; Mohr CP
    Dis Nerv Syst; 1969 Apr; 30(4):250-3. PubMed ID: 4890010
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug information: antiparkinson agents].
    Veje JO
    Sygeplejersken; 1981 Aug; 81(32):10. PubMed ID: 6913211
    [No Abstract]   [Full Text] [Related]  

  • 20. Deprenyl's neuroprotective action remains unresolved.
    van Hilten JJ; Bloem BR; Klaassen AA
    Ann Neurol; 1996 Aug; 40(2):266-7. PubMed ID: 8773615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.